Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brenner

Showing results (811-820 of 845) with videos related to

Pageof 85
Sort By:
Diabetes, Obesity & Metabolism|October 30, 2015
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trialH J L Heerspink, T Ninomiya, F Persson, et al.
The New England Journal of Medicine|November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetesHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL studyWilliam F Keane, Zhongxin Zhang, Paulette A Lyle, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|April 7, 2010
Evolution of elastic x-ray scattering in laser-shocked warm dense lithiumN L Kugland, G Gregori, S Bandyopadhyay, et al.
American Journal of Human Genetics|September 22, 2001
Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlationD Rodriguez, F Gauthier, E Bertini, et al.
Teaching and Learning in Medicine|March 12, 2021
Changing Medical Education, Overnight: The Curricular Response to COVID-19 of Nine Medical SchoolsAndrew P Binks, Renée J LeClair, Joanne M Willey, et al.
Neurology|May 30, 2002
Molecular findings in symptomatic and pre-symptomatic Alexander disease patientsJ R Gorospe, S Naidu, A B Johnson, et al.
Diabetes Care|March 30, 2004
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL StudyJuliana C N Chan, Nelson M S Wat, Wing-Yee So, et al.
Journal of Hypertension|March 14, 2007
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studiesWouter B A Eijkelkamp, Zhongxin Zhang, Barry M Brenner, et al.
Contemporary Clinical Trials|February 21, 2012
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogeneticsNicholas J Talley, G Richard Locke, Linda M Herrick, et al.
Pageof 85

Showing results (811-820 of 845) with videos related to

Sort By:
Pageof 85
Diabetes, Obesity & Metabolism|October 30, 2015
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trialH J L Heerspink, T Ninomiya, F Persson, et al.
The New England Journal of Medicine|November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetesHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL studyWilliam F Keane, Zhongxin Zhang, Paulette A Lyle, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|April 7, 2010
Evolution of elastic x-ray scattering in laser-shocked warm dense lithiumN L Kugland, G Gregori, S Bandyopadhyay, et al.
American Journal of Human Genetics|September 22, 2001
Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlationD Rodriguez, F Gauthier, E Bertini, et al.
Teaching and Learning in Medicine|March 12, 2021
Changing Medical Education, Overnight: The Curricular Response to COVID-19 of Nine Medical SchoolsAndrew P Binks, Renée J LeClair, Joanne M Willey, et al.
Neurology|May 30, 2002
Molecular findings in symptomatic and pre-symptomatic Alexander disease patientsJ R Gorospe, S Naidu, A B Johnson, et al.
Diabetes Care|March 30, 2004
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL StudyJuliana C N Chan, Nelson M S Wat, Wing-Yee So, et al.
Journal of Hypertension|March 14, 2007
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studiesWouter B A Eijkelkamp, Zhongxin Zhang, Barry M Brenner, et al.
Contemporary Clinical Trials|February 21, 2012
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogeneticsNicholas J Talley, G Richard Locke, Linda M Herrick, et al.
Pageof 85